Valuation: Enovis Corporation

Market Cap 146.9Cr 128.67Cr 118.73Cr 109.71Cr 208.18Cr 14TCr 211.95Cr 1.42TCr 553.73Cr 6.88TCr 551.61Cr 539.53Cr 24TCr P/E 2026 *
210x
P/E 2027 * 26.4x
Enterprise Value 266.63Cr 233.55Cr 215.5Cr 199.13Cr 377.86Cr 25TCr 384.71Cr 2.58TCr 1.01TCr 12TCr 1TCr 979.29Cr 43TCr EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.03x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-7.41%
1 week+14.15%
Current month+14.15%
1 month-0.63%
3 months+4.93%
6 months-14.66%
Current year-11.30%
1 week 20.23
Extreme 20.23
26.5
1 month 19.14
Extreme 19.14
26.5
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
36.82
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-7.41%+14.15%-28.44%-63.24% 146.9Cr
-0.88%+3.81%-16.73%+11.07% 13TCr
-1.36%+3.26%+1.53%-3.22% 1.29TCr
+1.53%+9.44%+50.76%+120.94% 884.4Cr
-0.46%-0.37%-49.18%-73.25% 387.17Cr
-1.81%+3.71%+20.09%+40.77% 265.47Cr
-1.60%-2.24%-12.94%-19.85% 179.73Cr
-1.01%+1.33%-2.43%-25.57% 161.37Cr
-1.56%+10.51%-61.15%-84.17% 144.3Cr
Average -1.62%+4.96%-10.94%-10.72% 1.79TCr
Weighted average by Cap. -0.87%+4.71%-12.05%+12.18%

Financials

2026 *2027 *
Net sales 234.47Cr 205.37Cr 189.5Cr 175.1Cr 332.27Cr 22TCr 338.29Cr 2.27TCr 883.81Cr 11TCr 880.42Cr 861.14Cr 38TCr 246.65Cr 216.05Cr 199.36Cr 184.21Cr 349.54Cr 24TCr 355.88Cr 2.39TCr 929.75Cr 12TCr 926.19Cr 905.91Cr 40TCr
Net income 29.6L 25.93L 23.92L 22.11L 41.95L 28Cr 42.71L 2.87Cr 1.12Cr 14Cr 1.11Cr 1.09Cr 48Cr 5.42Cr 4.75Cr 4.38Cr 4.05Cr 7.68Cr 518.04Cr 7.82Cr 53Cr 20Cr 254.01Cr 20Cr 20Cr 881.56Cr
Net Debt 119.73Cr 104.88Cr 97Cr 89Cr 169.68Cr 11TCr 172.76Cr 1.16TCr 451.33Cr 5.61TCr 449.6Cr 439.76Cr 19TCr 106.59Cr 93Cr 86Cr 80Cr 151.05Cr 10TCr 153.79Cr 1.03TCr 401.79Cr 4.99TCr 400.25Cr 391.49Cr 17TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
08/26/08 $23.63 -7.41% 11,70,291
07/26/07 $25.52 -1.47% 9,89,227
06/26/06 $25.90 +15.11% 21,55,004
02/26/02 $22.50 +12.28% 13,02,522
01/26/01 $20.04 -3.19% 15,02,881
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
25.52USD
Average target price
41.90USD
Spread / Average Target
+64.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock